Optical coherence tomography-based freeze-drying microscopy

Biomedical Optics Express

Volumn 3, Issue 1, 2012, Pages 55-63

  Mujat, Mircea ^a   Greco, Kristyn ^b   Galbally Kinney, Kristin L ^a   Hammer, Daniel X ^a   Daniel Ferguson, R ^a   Iftimia, Nicusor ^a   Mulhall, Phillip ^a   Sharma, Puneet ^b   Pikal, Michael J ^b   Kessler, William J ^a  

^a PHYSICAL SCIENCES INC   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG PRODUCTS; LOW TEMPERATURE DRYING; OPTICAL TOMOGRAPHY; PRODUCT DESIGN; TOMOGRAPHY;

CRITICAL TEMPERATURES; FREEZE-DRYING PROCESS; LATERAL RESOLUTION; MANUFACTURING PROCESS; PHARMACEUTICAL FORMULATION; PHARMACEUTICAL PRODUCTS; STRUCTURAL IMAGING; TIME DOMAIN OPTICAL COHERENCE TOMOGRAPHY;

DRYING;

EID: 84863903186     PISSN: None     EISSN: 21567085     Source Type: Journal    
DOI: 10.1364/BOE.3.000055     Document Type: Article

References (36)

1. C. Arnst, A. Weintraub, J. Carey, K. Capell, and M. Arndt, "Biotech, finally," in Business Week, June 13, 2005, issue 3937, http://www.businessweek.com/magazine/content/05_24/b3937001_mz001.htm.
2. M. J. Pikal and S. Shah. "The collapse temperature in freeze drying: dependence on measurement methodology and rate of water removal from the glassy phase," Int. J. Pharm. 62(2-3), 165-186 (1990).
3. X. Tang and M. J. Pikal. "Design of freeze-drying processes for pharmaceuticals: practical advice," Pharm. Res. 21(2), 191-200 (2004).
4. E. Meister and H. Gieseler. "Freeze-dry microscopy of protein/sugar mixtures: drying behavior, interpretation of collapse temperatures and a comparison to corresponding glass transition data," J. Pharm. Sci. 98(9), 3072-3087 (2009).
5. D. Huang, E. A. Swanson, C. P. Lin, J. S. Schuman, W. G. Stinson, W. Chang, M. R. Hee, T. Flotte, K. Gregory, C. A. Puliafito, and J. G. Fujimoto, "Optical coherence tomography," Science 254(5035), 1178-1181 (1991).
6. A. F. Fercher, W. Drexler, C. K. Hitzenberger, and T. Lasser. "Optical coherence tomography - principles and applications," Rep. Prog. Phys. 66(2), 239-303 (2003).
7. K. Kobayashi, J. A. Izatt, M. D. Kulkarni, J. Willis, and M. V. Sivak, Jr. "High-resolution cross-sectional imaging of the gastrointestinal tract using optical coherence tomography: preliminary results," Gastrointest. Endosc. 47(6), 515-523 (1998).
8. B. D. MacNeill, H. C. Lowe, E. Pomeranstev, D. DeJoseph, H. Yabushita, G. J. Tearney, B. E. Bouma, and I. K. Jang. "In-vivo characterization of plaque morphology by optical coherence tomography predicts coronary artery remodeling," J. Am. Coll. Cardiol. 41(6), 42 (2003).
9. S. H. Yun, G. J. Tearney, J. F. de Boer, N. Iftimia, and B. E. Bouma. "High-speed optical frequency-domain imaging," Opt. Express 11(22), 2953-2963 (2003).
10. B. Cense, N. Nassif, T. C. Chen, M. C. Pierce, S. H. Yun, B. H. Park, B. E. Bouma, G. J. Tearney, and J. F. de Boer. "Ultrahigh-resolution high-speed retinal imaging using spectral-domain optical coherence tomography," Opt. Express 12(11), 2435-2447 (2004).
11. A. F. Fercher, C. K. Hitzenberger, G. Kamp, and S. Y. El-Zaiat. "Measurements of intraocular distances by backscattering spectral interferometry," Opt. Commun. 117(1-2), 43-48 (1995).
12. M. Wojtkowski, R. Leitgeb, A. Kowalczyk, T. Bajraszewski, and A. F. Fercher. "In vivo human retinal imaging by Fourier domain optical coherence tomography," J. Biomed. Opt. 7(3), 457-463 (2002).
13. J. F. de Boer, B. Cense, B. H. Park, M. C. Pierce, G. J. Tearney, and B. E. Bouma. "Improved signal-to-noise ratio in spectral-domain compared with time-domain optical coherence tomography," Opt. Lett. 28(21), 2067-2069 (2003).
14. R. Leitgeb, C. K. Hitzenberger, and A. F. Fercher. "Performance of fourier domain vs. time domain optical coherence tomography," Opt. Express 11(8), 889-894 (2003).
15. B. M. Hoeling, A. D. Fernandez, R. C. Haskell, E. Huang, W. R. Myers, D. C. Petersen, S. E. Ungersma, R. Y. Wang, M. E. Williams, and S. E. Fraser. "An optical coherence microscope for 3-dimensional imaging in developmental biology," Opt. Express 6(7), 136-146 (2000).
16. F. Lexer, C. K. Hitzenberger, W. Drexler, S. Molebny, H. Sattmann, M. Sticker, and A. F. Fercher. "Dynamic coherent focus OCT with depth-independent transversal resolution," J. Mod. Opt. 46, 541-553 (1999).
17. M. Pircher, E. Götzinger, and C. K. Hitzenberger, "Dynamic focus in optical coherence tomography for retinal imaging," J. Biomed. Opt. 11(5), 054013 (2006).
18. L. An and R. K. Wang, "Use of a scanner to modulate spatial interferograms for in vivo full-range Fourier-domain optical coherence tomography," Opt. Lett. 32(23), 3423-3425 (2007).
19. B. Baumann, M. Pircher, E. Götzinger, and C. K. Hitzenberger, "Full range complex spectral domain optical coherence tomography without additional phase shifters," Opt. Express 15(20), 13375-13387 (2007).
20. A. F. Fercher, R. Leitgeb, C. K. Hitzenberger, H. Sattmann, and M. Wojtkowski, "Complex spectral interferometry OCT," Proc. SPIE 3564, 173-178 (1998).
21. E. Götzinger, M. Pircher, R. A. Leitgeb, and C. K. Hitzenberger, "High speed full range complex spectral domain optical coherence tomography," Opt. Express 13(2), 583-594 (2005).
22. R. A. Leitgeb, C. K. Hitzenberger, A. F. Fercher, and T. Bajraszewski, "Phase-shifting algorithm to achieve high-speed long-depth-range probing by frequency-domain optical coherence tomography," Opt. Lett. 28(22), 2201-2203 (2003).
23. R. A. Leitgeb, R. Michaely, T. Lasser, and S. C. Sekhar, "Complex ambiguity-free Fourier domain optical coherence tomography through transverse scanning," Opt. Lett. 32(23), 3453-3455 (2007).
24. M. Wojtkowski, A. Kowalczyk, R. Leitgeb, and A. F. Fercher, "Full range complex spectral optical coherence tomography technique in eye imaging," Opt. Lett. 27(16), 1415-1417 (2002).
25. A. G. Podoleanu, J. A. Rogers, D. A. Jackson, and S. Dunne, "Three dimensional OCT images from retina and skin," Opt. Express 7(9), 292-298 (2000).
26. K. Greco, M. Mujat, K. L. Galbally-Kinney, D. X. Hammer, R. D. Ferguson, N. Iftimia, P. Mulhall, P. Sharma, W. J. Kessler, and M. J. Pikal, "Accurate prediction of collapse temperature using optical coherence tomography (OCT) based freeze drying microscopy," Submitted to J. Pharm. Sci.
27. A. A. Barresi, S. Ghio, D. Fissore, and R. Pisano, "Freeze drying of pharmaceutical excipients close to collapse temperature: influence of the process conditions on process time and product quality," Drying Technol. 27(6), 805-816 (2009).
28. K. Chatterjee, E. Y. Shalaev, and R. Suryanarayanan, "Partially crystalline systems in lyophilization: II. Withstanding collapse at high primary drying temperatures and impact on protein activity recovery," J. Pharm. Sci. 94(4), 809-820 (2005).
29. J. D. Colandene, L. M. Maldonado, A. T. Creagh, J. S. Vrettos, K. G. Goad, and T. M. Spitznagel, "Lyophilization cycle development for a high-concentration monoclonal antibody formulation lacking a crystalline bulking agent," J. Pharm. Sci. 96(6), 1598-1608 (2007).
30. F. Fonseca, S. Passot, O. Cunin, and M. Marin, "Collapse temperature of freeze-dried Lactobacillus bulgaricus suspensions and protective media," Biotechnol. Prog. 20(1), 229-238 (2004).
31. R. E. Johnson, M. E. Oldroyd, S. S. Ahmed, H. Gieseler, and L. M. Lewis, "Use of manometric temperature measurements (MTM) to characterize the freeze-drying behavior of amorphous protein formulations," J. Pharm. Sci. 99(6), 2863-2873 (2010).
32. L. M. Lewis, R. E. Johnson, M. E. Oldroyd, S. S. Ahmed, L. Joseph, I. Saracovan, and S. Sinha, "Characterizing the freeze-drying behavior of model protein formulations," AAPS PharmSciTech 11(4), 1580-1590 (2010).
33. D. E. Overcashier, T. W. Patapoff, and C. C. Hsu, "Lyophilization of protein formulations in vials: investigation of the relationship between resistance to vapor flow during primary drying and small-scale product collapse," J. Pharm. Sci. 88(7), 688-695 (1999).
34. A. Parker, S. Rigby-Singleton, M. Perkins, D. Bates, D. le Roux, C. J. Roberts, C. Madden-Smith, L. Lewis, D. L. Teagarden, R. E. Johnson, and S. S. Ahmed, "Determination of the influence of primary drying rates on the microscale structural attributes and physicochemical properties of protein containing lyophilized products," J. Pharm. Sci. 99(11), 4616-4629 (2010).
35. S. C. Schneid, P. M. Stärtzel, P. Lettner, and H. Gieseler, "Robustness testing in pharmaceutical freeze-drying: Inter-relation of process conditions and product quality attributes studied for a vaccine formulation," Pharm. Dev. Technol. 16(6), 583-590 (2011).
36. D. Q. Wang, J. M. Hey, and S. L. Nail. "Effect of collapse on the stability of freeze-dried recombinant factor VIII and α-amylase," J. Pharm. Sci. 93(5), 1253-1263 (2004).